- Home
- KOPN vs ENGN Comparison
KOPN vs ENGN Comparison
Compare KOPN & ENGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KOPN
- ENGN
- Stock Information
- Founded
- KOPN 1984
- ENGN 1999
- Country
- KOPN United States
- ENGN Canada
- Employees
- KOPN N/A
- ENGN N/A
- Industry
- KOPN Semiconductors
- ENGN
- Sector
- KOPN Technology
- ENGN
- Exchange
- KOPN Nasdaq
- ENGN Nasdaq
- Market Cap
- KOPN 255.1M
- ENGN 204.3M
- IPO Year
- KOPN 1992
- ENGN N/A
- Fundamental
- Price
- KOPN $1.58
- ENGN $3.83
- Analyst Decision
- KOPN Strong Buy
- ENGN Buy
- Analyst Count
- KOPN 3
- ENGN 7
- Target Price
- KOPN $2.58
- ENGN $23.29
- AVG Volume (30 Days)
- KOPN 3.1M
- ENGN 97.4K
- Earning Date
- KOPN 08-07-2025
- ENGN 06-12-2025
- Dividend Yield
- KOPN N/A
- ENGN N/A
- EPS Growth
- KOPN N/A
- ENGN N/A
- EPS
- KOPN N/A
- ENGN N/A
- Revenue
- KOPN $50,841,018.00
- ENGN N/A
- Revenue This Year
- KOPN $8.02
- ENGN N/A
- Revenue Next Year
- KOPN $20.99
- ENGN N/A
- P/E Ratio
- KOPN N/A
- ENGN N/A
- Revenue Growth
- KOPN 28.16
- ENGN N/A
- 52 Week Low
- KOPN $0.56
- ENGN $2.65
- 52 Week High
- KOPN $2.17
- ENGN $11.00
- Technical
- Relative Strength Index (RSI)
- KOPN 55.40
- ENGN 57.73
- Support Level
- KOPN $1.44
- ENGN $2.95
- Resistance Level
- KOPN $1.64
- ENGN $3.44
- Average True Range (ATR)
- KOPN 0.09
- ENGN 0.26
- MACD
- KOPN -0.02
- ENGN 0.08
- Stochastic Oscillator
- KOPN 53.85
- ENGN 82.86
About KOPN Kopin Corporation
Kopin Corp is a provider of high-performance application-specific optical solutions consisting of high-resolution microdisplays and optics, subassemblies, and headsets. It serves soldiers, avionics, armored vehicles training and simulation military applications, and others. Its product portfolio includes Microdisplays, Spatial Light Modulators, Optical Modules, Medical, Training, and Simulation. Geographically, it derives a majority of its revenue from the Americas and also has a presence in Asia-Pacific; Europe, and Other Countries.
About ENGN enGene Holdings Inc.
enGene Holdings Inc is a clinical-stage biotechnology company focused on developing gene therapies to improve the lives of patients. The Company is developing non-viral gene therapies based on its novel and proprietary dually derived chitosan, or DDX, gene delivery platform, which allows localized delivery of multiple gene cargos directly to mucosal tissues and other organs.